Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Gadolinium containing contrast agents - Important Safety Information from the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
01/02/2011
Problem Or Issue:
Important safety information communication from the Irish Medicines Board on the risk of Nephrogenic Systemic Fibrosis (NSF) with gadolinium-containing contrast agents (GdCAs).
Important Safety Information - Gadolinium containing contrast agents
« Back
Date Printed: 04/05/2024